Kainic acid (KA) causes
seizures and neuronal loss in the hippocampus. The present study investigated whether a recreational schedule of 3,4-methylenedioxymethamphetamine (
MDMA) favours the development of a seizure state in a model of KA-induced
epilepsy and potentiates the toxicity profile of KA (20 or 30mg/kg). Adolescent male C57BL/6 mice received saline or
MDMA t.i.d. (s.c. every 3h), on 1day a week, for 4 consecutive weeks. Twenty-four hours after the last
MDMA exposure, the animals were injected with saline or KA (20 or 30mg/kg). After this injection, we evaluated
seizures, hippocampal neuronal cell death, microgliosis,
astrogliosis, and
calcium binding proteins.
MDMA pretreatment, by itself, did not induce neuronal damage but increased seizure susceptibility in all KA treatments and potentiated the presence of
Fluoro-Jade-positive cells in CA1. Furthermore,
MDMA, like KA, significantly decreased
parvalbumin levels in CA1 and dentate gyrus, where it potentiated the effects of KA. The
amphetamine derivative also promoted a transient decrease in
calbindin and
calretinin levels, indicative of an abnormal neuronal discharge. In addition, treatment of cortical neurons with
MDMA (10-50μM) for 6 or 48h significantly increased basal Ca(2+), reduced basal Na(+) levels and potentiated
kainate response. These results indicate that
MDMA potentiates KA-induced neurodegeneration and also increases KA seizure susceptibility. The mechanism proposed includes changes in
Calcium Binding Proteins expression, probably due to the disruption of intracellular ionic homeostasis, or/and an indirect effect through
glutamate release.